Psychiatry and Neurology, Neurology · Roseville, MN
NPI
1023227162
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
2720 Fairview Ave N Ste 100
Roseville, MN, 55113
Phone (651) 241-5290
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
452 services
Medicare patients, 2024
211
Average age 58
Drug cost, 2024
$2.2M
4,777 prescriptions
Company payments, 2025
$18K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul B Atkinson was code 95720 (neurologic), 146 times for 89 patients. In total Paul B Atkinson billed 452 services in 23 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 146 | 89 | $154.37 | $23K |
| 99214 Office E&M - Established | Office | 67 | 60 | $76.09 | $5,098 |
| 99232 Hospital E&M - Subsequent | Facility | 62 | 26 | $58.91 | $3,652 |
| 99213 Office E&M - Established | Office | 35 | 33 | $62.37 | $2,183 |
| 99215 Office E&M - Established | Office | 32 | 22 | $135.63 | $4,340 |
| 95718 Neurologic | Facility | 29 | 29 | $100.26 | $2,908 |
| 95970 Electrical Nerve Conductivity | Office | 21 | 13 | $11.67 | $245 |
By year: 2022 $49K for 472 services; 2023 $47K for 487 services; 2024 $46K for 452 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paul B Atkinson prescribed most often to Medicare patients was Levetiracetam, with 671 prescriptions and refills. In total Paul B Atkinson wrote 4,777 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 671 | 982 | 91 | $27K |
| Lamotrigine Generic | 536 | 774 | 62 | $19K |
| Lacosamide Generic | 445 | 483 | 43 | $88K |
| Topiramate Generic | 337 | 359 | 20 | $7,366 |
| Briviact Brivaracetam | 256 | 284 | 22 | $508K |
| Pregabalin Generic | 209 | 224 | 18 | $6,909 |
| Divalproex Sodium Er Divalproex Sodium | 193 | 286 | 25 | $10K |
| Felbamate Generic | 189 | 240 | 19 | $63K |
| Zonisamide Generic | 184 | 222 | 20 | $7,039 |
| Oxcarbazepine Generic | 128 | 159 | 12 | $10K |
| Lamotrigine Er Lamotrigine | 108 | 140 | Under 11 | $28K |
| Vimpat Lacosamide | 104 | 104 | Under 11 | $120K |
| Clobazam Generic | 85 | 86 | Under 11 | $11K |
| Gabapentin Generic | 76 | 100 | Under 11 | $1,102 |
| Clonazepam Generic | 62 | 67 | Under 11 | $620 |
Brand drugs: 905 claims; generic drugs: 3,809 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul B Atkinson $18K ($18K in general payments such as food, travel and fees) from 4 companies. The largest payer was Jazz Pharmaceuticals Inc. with $13K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.